RESEARCH ARTICLE
Nobel Med 2005; 1(2): 20-23

IS MEAN PLATELET VOLUME A RISK FACTOR FOR MYOCARDIAL INFARCTION?

Ahmet Uludağ, Müjdat Batur Canöz, Füsun Erdenen, Cüneyt Müderrisoğlu, Betül Canöz
ABSTRACT
In this research, we investigated the relationship between myocardial infarction and mean platelet volume (MPV).114 patients with acute myocardial infarction (AMI) and 61 healthy subjects were enrolled in this study. AMI was diagnosed by clinical history, electrocardiographic findings and elevated CK-MB levels. Platelet counts and volumes were measured with Sysmex SE 9000 Coulter Counter. Student t test was used for statistical analysis. In infarction group mean MPV levels were 11.51 ± 1.08 fl ;whereas in healthy controls it was 10.16±1.08 fl. (p:0.0005) .Platelet counts were 215.63 ± 54.42 x103/l in infarction patients and 280.34±105.57x 103l in healthy subjects (p:0.0005). Based on these results, we suggest that low platelet count and high MPV might be risk factors for AMI.
Keywords
Mean platelet volume Myocardial infarction Platelet count

Article Details

Download Full Text in PDF Format Read Full Text Other Articles in This Issue

ANAPHYLAXIS

04-07

Füsun Erdenen

REVIEW Nobel Med 2005; 1(2): 04-07

EXTRACT FROM THE RHEUMATOID ARTHRITIS THERAPY AT THE AMERICAN COLLAGE OF RHEUMATOLOGY - 2004

08-11

Mustafa Kaplan, Burak Şahan, Emrullah Solmazgül, Selim Nalbant

REVIEW Nobel Med 2005; 1(2): 08-11

EXTRACT FROM THE RHEUMATOID ARTHRITIS THERAPY AT THE AMERICAN COLLAGE OF RHEUMATOLOGY - 2004

12-19

Levent Tütüncü, Nursel Arslanhan, Ercüment Müngen , Seçkin Yılmaz, Yusuf Z. Yergök

REVIEW Nobel Med 2005; 1(2): 12-19

IS MEAN PLATELET VOLUME A RISK FACTOR FOR MYOCARDIAL INFARCTION?

20-23

Ahmet Uludağ, Müjdat Batur Canöz, Füsun Erdenen, Cüneyt Müderrisoğlu, Betül Canöz

RESEARCH ARTICLE Nobel Med 2005; 1(2): 20-23

THE VALUE OF D-DIMER TEST IN DIAGNOSIS OF PULMONARY THROMBOEMBOLISM AND DEEP VENOUS THROMBOSIS

24-27

Mine Tijen Cesur, Emrullah Solmazgül, Ejder Kardeşoğlu, Nurittin Ardıç, Namık Özmen, Zekai Pekkafalı, Yavuz Narin, Yaşar Küçükardalı

RESEARCH ARTICLE Nobel Med 2005; 1(2): 24-27

NAPROXEN SODIUM - INDUCED TOXIC EPIDERMAL NECROLYSIS A CASE REPORT

28-31

Özcan Keskin, İsmail Yıldırım, Murat Kalemoğlu, Yaşar Küçükardalı, Fuat Yüksel

REPORT Nobel Med 2005; 1(2): 28-31

MORBUS BEHÇET

32-33

Nil Sarı, Esin Karlıkaya, İbrahim Topçu, Elif Vatanoğlu, Ümit Zeyneb Belbez, Ahmet Doğan Ataman, Ferda Gündoğdu, Ümit Emrah Kurt, Necla Kınık

A PORTRAIT Nobel Med 2005; 1(2): 32-33

AKCIĞER EMBOLISINDE TANI

34-35

Mustafa Erelel

EDITORIAL Nobel Med 2005; 1(2): 34-35

OSTEOPOROZ TEDAVISINDE IKILI ANTIREZORPTIF KULLANILMALI MI?

36

Cihan Aksoy

EDITORIAL Nobel Med 2005; 1(2): 36

LIVER AND SYSTEMIC DISEASES

05-09

Sebati Özdemir

REVIEW Nobel Med 2013; 9(2): 5-9

AGING KIDNEY: SENESCENCE OR DISEASE?

10-14

Meltem Gürsu, Rümeyza Kazancıoğlu, Savaş Öztürk

REVIEW Nobel Med 2013; 9(2): 10-14

IMPORTANCE OF HOLOTRANSCOBALAMIN (HOLOTC) MEASUREMENTS IN EARLY DIAGNOSIS OF COBALAMIN DEFICIENCY, ESPECIALLY IN PATIENTS WITH BORDERLINE VITAMIN B12 CONCENTRATIONS

15-20

Faruk Sönmezışık, Esma Sürmen Gür, Burak Asıltaş

RESEARCH ARTICLE Nobel Med 2013; 9(2): 15-20

EVALUATION OF PHYSICAL GROWTH IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

21-25

Celalettin Koşan, Oğuzhan Sepetçigil, Atilla Çayır, Avni Kaya, Behzat Özkan

RESEARCH ARTICLE Nobel Med 2013; 9(2): 21-25

COMPARISON OF RISK INDEXES USED IN DETERMINING THE POSTOPERATIVE RESPIRATORY INSUFFICIENCY RISK

26-31

Gülsüm Kavalcı, Cavidan Arar, Alkın Çolak, Nesrin Turan, Cemil Kavalcı

RESEARCH ARTICLE Nobel Med 2013; 9(2): 26-31

THE EVALUATION OF PRENATAL AND ENVIROMENTAL RISK FACTORS IN CHILDREN WITH ASTHMA, ALLERGIC RHINITIS AND BRONCHIAL ASTHMA ABSTRACT

32-37

Mehmet İbrahim Turan, Müferet Ergüven, Mehmet Özdemir

RESEARCH ARTICLE Nobel Med 2013; 9(2): 32-37

REOPERATIONS AND MORBIDITY IN THYROID SURGERY

38-42

Serkan Teksöz, Murat Özcan, Aytül Sargan, Yusuf Bukey, Recep Özgültekin, Ateş Özyeğin

RESEARCH ARTICLE Nobel Med 2013; 9(2): 38-42

EFFECTS OF RAMADAN FASTING ON BLOOD PRESSURE CONTROL, LIPID PROFILE, BRAIN NATRIURETIC PEPTIDE, RENAL FUNCTIONS AND ELECTROLYTE LEVELS IN HYPERTENSIVE PATIENTS TAKING COMBINATION THERAPY

43-46

İbrahim Faruk Aktürk, İsmail Bıyık, Cüneyt Koşaş, Ahmet Arif Yalçın, Mehmet Ertürk, Fatih Uzun

RESEARCH ARTICLE Nobel Med 2013; 9(2): 43-46

MANAGEMENT OF A LARGE OUTBREAK CAUSED BY NOROVIRUS AND CAMPYLOBACTER JEJUNI OCCURRED IN A RURAL AREA IN TURKEY

47-51

İbak Gönen

RESEARCH ARTICLE Nobel Med 2013; 9(2): 47-51

FREQUENT CD99 AND FLI-1 EXPRESSIONS IN DIFFUSE LARGE B-CELL LYMPHOMA AND THEIR ASSOCIATION WITH PROLIFERATIVE AND APOPTOTIC RATES

52-56

Ufuk Berber, İsmail Yılmaz, Tolga Tuncel, Zafer Küçükodacı Aptullah Haholu

RESEARCH ARTICLE Nobel Med 2013; 9(2): 52-56
  • Pubmed Style
    Ahmet Uludağ, Müjdat Batur Canöz, Füsun Erdenen, Cüneyt Müderrisoğlu, Betül Canöz. [ORTALAMA TROMBOSİT HACMİ (MPV) MYOKARD İNFARKTÜSÜ İÇİN BİR RİSK FAKTÖRÜ MÜ?]. Nobel Med 2005; 1(2): 20-23, Turkish.
  • Web Style
    Ahmet Uludağ, Müjdat Batur Canöz, Füsun Erdenen, Cüneyt Müderrisoğlu, Betül Canöz. [ORTALAMA TROMBOSİT HACMİ (MPV) MYOKARD İNFARKTÜSÜ İÇİN BİR RİSK FAKTÖRÜ MÜ?]. www.nobelmedicus.com/en/Article.aspx?m=1716 [Access: Mayıs 24, 2021], Turkish.
  • AMA (American Medical Association) Style
    Ahmet Uludağ, Müjdat Batur Canöz, Füsun Erdenen, Cüneyt Müderrisoğlu, Betül Canöz. [ORTALAMA TROMBOSİT HACMİ (MPV) MYOKARD İNFARKTÜSÜ İÇİN BİR RİSK FAKTÖRÜ MÜ?]. Nobel Med 2005; 1(2): 20-23, Turkish.
  • Vancouver/ICMJE Style
    Ahmet Uludağ, Müjdat Batur Canöz, Füsun Erdenen, Cüneyt Müderrisoğlu, Betül Canöz. [ORTALAMA TROMBOSİT HACMİ (MPV) MYOKARD İNFARKTÜSÜ İÇİN BİR RİSK FAKTÖRÜ MÜ?]. Nobel Med (2005); 1(2): 20-23, [cited Mayıs 24, 2021], Turkish.
  • Harvard Style
    Ahmet Uludağ, Müjdat Batur Canöz, Füsun Erdenen, Cüneyt Müderrisoğlu, Betül Canöz. (2005) [ORTALAMA TROMBOSİT HACMİ (MPV) MYOKARD İNFARKTÜSÜ İÇİN BİR RİSK FAKTÖRÜ MÜ?]. Nobel Med, 1(2): 20-23, Turkish.